NDC 71894-110 - Zolgensma
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71894-110
- Package NDCs from labels
- 71894-110-01
- Manufacturer
- Novartis Innovative Technologies Inc.
- Effective date
- 2026-06-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zolgensma - Novartis Innovative Technologies Inc. | Novartis Innovative Technologies Inc. | 2026-06-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bacteriostatic Water | BACTERIOSTATIC WATER | Fujian Genohope Biotech Ltd. | 54f66b82-c9e5-a2bc-e063-6394a90adbbc | 2026-06-23 | 059QF0KO0R | |
| Isopropyl Rubbing Alcohol 70 | ISOPROPYL ALCOHOL | Delon Laboratories (1990) Ltd. | fb481568-0c51-421f-9b73-adb4c84645aa | 2026-06-22 | Warnings | ND2M416302 |
| Medline | ISOPROPYL ALCOHOL | Medline Industries, LP | 495076e9-3187-6bfa-e063-6394a90a01f5 | 2026-06-22 | Warnings | 797544 ND2M416302 |
| ABRILADA | ADALIMUMAB-AFZB | A-S Medication Solutions | 79943fe6-1249-4074-9aed-c53937820d0f | 2026-06-18 | Boxed warning, Warnings, Adverse reactions | 797544 |
| Isopropyl alcohol 91 percent | ISOPROPYL ALCOHOL | P & L Development, LLC | fcda76cb-63c4-4e81-9e0a-13be506a8150 | 2026-06-17 | Warnings | ND2M416302 |
| Humalog KwikPen | INSULIN LISPRO | Eli Lilly and Company | c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f | 2026-06-16 | Warnings, Adverse reactions | 059QF0KO0R |
| 0.9% Sodium Chloride Saline Solution | SODIUM CHLORIDE | Yunqi Cosmetics (Shenzhen) Co., Ltd | 546af257-dbd1-11fc-e063-6394a90a8e0a | 2026-06-16 | Warnings | 451W47IQ8X |
| Zolgensma | ONASEMNOGENE ABEPARVOVEC-XIOI | Novartis Innovative Technologies Inc. | 68cd4f06-70e1-40d8-bedb-609ec0afa471 | 2026-06-16 | Boxed warning, Warnings, Adverse reactions | BLA125694 71894-128-05 71894-143-10 71894-126-04 71894-145-11 71894-110-01 71894-120-02 71894-135-07 71894-138-08 71894-137-08 71894-156-14 71894-127-05 71894-139-09 71894-115-01 71894-129-05 71894-146-11 71894-142-10 71894-121-03 71894-133-07 71894-140-09 71894-155-14 71894-136-08 71894-123-03 71894-132-06 71894-148-12 71894-154-14 71894-125-04 71894-150-12 71894-152-13 71894-153-13 71894-122-03 71894-147-11 71894-134-07 71894-149-12 71894-151-13 71894-131-06 71894-130-06 71894-144-10 71894-141-09 71894-124-04 71894-148 71894-123 71894-149 71894-134 71894-145 71894-156 71894-138 71894-144 71894-120 71894-146 71894-136 71894-121 71894-135 71894-137 71894-139 71894-143 71894-152 71894-140 71894-122 71894-147 71894-129 71894-130 71894-153 71894-154 71894-125 71894-141 71894-131 71894-124 71894-133 71894-155 71894-142 71894-151 71894-126 71894-128 71894-132 71894-150 71894-127 2170288 2630781 2630865 2630863 2630840 2170290 2630864 2630773 2170254 2630839 2170260 2630859 2170245 2170250 2170281 2170241 2170248 2170292 2170246 2170283 2170264 2170270 2170294 2630861 2630767 2170293 2630779 2170295 2630833 2170275 2630858 2170257 2630787 2170261 2630862 2630775 2630785 2630765 2630771 2170256 2170258 2630860 2170273 2170284 2170267 2170274 2170278 2630832 2630790 2170297 2630777 2170262 2170291 2170289 2170279 2630783 2170244 2170255 797544 2630769 2170265 2170249 2170276 2170253 2630855 2170296 2170252 2170251 2170266 2170247 2170272 2630857 2630856 2630761 2630763 2170282 2170259 2170263 2170239 7039f121-a56c-49ba-bca9-28b7bc6afbcb 68cd4f06-70e1-40d8-bedb-609ec0afa471 |
| Skyrizi | RISANKIZUMAB-RZAA | AbbVie Inc. | 7148c8eb-b39e-e20a-6494-a6df82392858 | 2026-06-15 | Warnings, Adverse reactions | 797544 |
| BM BM68 DROPS | ARGENTUM NIT, BARYTA CARB., DULCAMARA, GELSEMIUM, KALI BROM, NAT MUR, CAUSTICUM | BM Private Limited | 53f9c99a-0f20-0358-e063-6394a90af4e0 | 2026-06-15 | Warnings | 451W47IQ8X |
| BM BM68 | ARGENTUM NIT, BARYTA CARB, DULCAMARA, GELSEMIUM, KALI BROM, NAT MUR, CAUSTICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5448c76a-2ecb-9402-e063-6294a90a6ad7 | 2026-06-15 | Warnings | 451W47IQ8X |
| BM BIO28 ALCOHOL | CALC SULPH, CALC FLUOR, CALC PHOS, FERR PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT PHOS, NAT SULPH, NAT MUR, SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 544b66c4-49df-556f-e063-6394a90af3ed | 2026-06-15 | Warnings | 451W47IQ8X |
| 70% | ISOPROPYL ALCOHOL | Meijer, Inc. | 7b1f93ff-5eeb-4da1-8f02-7c47d713689a | 2026-06-15 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Meijer, Inc. | 531cea18-9609-4d78-876d-3ba5d2d1e16f | 2026-06-15 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Meijer, Inc. | b0d302c2-58a0-4c3e-9c4a-fd34de40c034 | 2026-06-15 | Warnings, Adverse reactions | ND2M416302 |
| Male Support | AGNUS CASTUS, AURUM METALLICUM, BENZOICUM ACIDUM, BRYONIA (ALBA), BUFO RANA, CALADIUM SEGUINUM, CHIMAPHILA UMBELLATA, CLEMATIS ERECTA, CONIUM MACULATUM, CORTISONE ACETICUM, HYPOTHALAMUS SUIS, KALI ARSENICOSUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PROSTATE (SUIS), RHODODENDRON CHRYSANTHUM, SABAL SERRULATA, SELENIUM METALLICUM, SEPIA, TESTOSTERONE, THUJA OCCIDENTALIS | Deseret Biologicals, Inc. | 29cefc89-3bb6-484e-84ab-116b5827a4c3 | 2026-06-15 | Warnings | 451W47IQ8X |
| BM BM68 DROPS | ARGENTUM NIT, BARYTA CARB., DULCAMARA, GELSEMIUM, KALI BROM, NAT MUR, CAUSTICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5410ec88-8c65-3b26-e063-6294a90adf07 | 2026-06-12 | Warnings | 451W47IQ8X |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 54113d1f-e8e7-6b4c-e063-6394a90a0edf | 2026-06-12 | Warnings | 059QF0KO0R |
| V HP | ANAS BARBARIAE, HEPATIS ET CORDIS EXTRACTUM, ARSENICUM ALBUM, BELLADONNA, BRYONIA (ALBA), CARCINOSIN, ECHINACEA (ANGUSTIFOLIA), EUPATORIUM PERFOLIATUM, GELSEMIUM SEMPERVIRENS, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, PYROGENIUM, RHUS TOX, SULPHUR | Energique, Inc. | ea12ca3b-19e0-4d4a-9514-4d28d214e1e7 | 2026-06-12 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Cardinal Health 107, LLC | 107af8bc-b6af-4b85-8c8a-ea757dcef1da | 2026-06-12 | Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.